These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32915939)

  • 1. Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black population.
    Bhatia ND; Werschler WP; Cook-Bolden FE; Guenin E
    Cutis; 2020 Jul; 106(1):45-50;E1. PubMed ID: 32915939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
    Lain E; Day D; Harper J; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
    Han G; Armstrong AW; Desai SR; Guenin E
    J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
    J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
    Stein Gold L; Pariser DM; Guenin E
    J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
    Cook-Bolden FE; Gold MH; Guenin E
    J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
    Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
    J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
    Harper JC; Baldwin H; Stein Gold L; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups.
    Harper JC; Roberts WE; Zeichner JA; Guenin E; Bhatt V; Pillai R
    J Dermatolog Treat; 2020 Mar; 31(2):160-167. PubMed ID: 30935257
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population.
    Eichenfield LF; Sugarman JL; Guenin E; Harris S; Bhatt V
    Pediatr Dermatol; 2019 Mar; 36(2):193-199. PubMed ID: 30656753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
    Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R
    J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris.
    Tyring SK; Kircik L; Pariser DM; Woolery-Lloyd HC; Harper JC; Bhatt V; Pillai R; Guenin E
    Am J Clin Dermatol; 2020 Dec; 21(6):891-899. PubMed ID: 32886337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials.
    Tanghetti EA; Werschler WP; Lain T; Guenin E; Martin G; Pillai R
    J Drugs Dermatol; 2020 Jan; 19(1):70-77. PubMed ID: 31985914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short contact therapy of acne with tretinoin.
    Veraldi S; Barbareschi M; Benardon S; Schianchi R
    J Dermatolog Treat; 2013 Oct; 24(5):374-6. PubMed ID: 23167277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
    Aschoff R; Möller S; Haase R; Kuske M
    J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
    Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study.
    Kircik LH
    J Drugs Dermatol; 2011 Jun; 10(6):586-90. PubMed ID: 21637899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
    Grimes P; Callender V
    Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
    Leyden JJ; Tanghetti EA; Miller B; Ung M; Berson D; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):12-9. PubMed ID: 12095064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.